GSK launches phase 3 programme for gepotidacin in uUTI and GC

This article was originally published here

The UK-based pharma company said that it has started dosing of patients in the phase 3 programme, which will test gepotidacin in two studies – EAGLE-1 and EAGLE-2.

The post GSK launches phase 3 programme for gepotidacin in uUTI and GC appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply